Difference between revisions of "Work Product for Review"

From QIBA Wiki
Jump to navigation Jump to search
 
(12 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 +
[[Image:QIBA_WIKI_BLURB.jpg|600px]]
 +
 +
<font color="red">NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE:</font> https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.
 +
 +
 
QIBA '''[[Profiles|Profile documents]]''' are posted for '''[[Public Comment Process|Public Comment]]''' to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.   
 
QIBA '''[[Profiles|Profile documents]]''' are posted for '''[[Public Comment Process|Public Comment]]''' to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.   
  
 
==Comment Submission==
 
==Comment Submission==
  
−
* Visit the [https://fs22.formsite.com/QIBA/QIBA_Public_Comment_Form/index.html QIBA Public Comment Webform].
+
* ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - ''see example'': [[Image:public comment form.jpg |1200px]]
−
:* Select the document you are commenting on from the dropdown menu
+
:* Select the document you are commenting on from the appropriate form
−
:* Provide your name or initials
+
:* Provide your name and email address
−
:* Follow the other instructions on the page
+
:* Add the Profile section and line number (if applicable) to which your comment refers
−
:* CLICK SUBMIT
+
:* Describe the issue and your propose a resolution
−
* e-mail ([mailto:sweinmann@rsna.org Susan Weinmann]) with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
+
:* When you have entered each of your comments, you may submit the form
 +
* e-mail Profile Authoring Group with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
  
−
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
+
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
  
 
==Public Comment Documents==
 
==Public Comment Documents==
−
''Public Comment closes March 1, 2017''
 
−
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: <font color=red>Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016</font>]]
 
−
*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA Profile Checklist: <font color=red>SPECT Profile Conformance</font>]]
 
−
 
−
''Public Comment closed''
 
−
*[[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: <font color=red> QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016</font>]]
 
−
 
−
*[[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|QIBA Spreadsheet: <font color=red> Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016 </font>]]
 
  
−
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: <font color=red> Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016 </font>]]
+
see http://qibawiki.rsna.org/index.php/Profiles
  
  
 
*[[Document Archive]]
 
*[[Document Archive]]

Latest revision as of 16:56, 19 January 2024

QIBA WIKI BLURB.jpg

NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE: https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.


QIBA Profile documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.

Comment Submission

  • ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - see example: Public comment form.jpg
  • Select the document you are commenting on from the appropriate form
  • Provide your name and email address
  • Add the Profile section and line number (if applicable) to which your comment refers
  • Describe the issue and your propose a resolution
  • When you have entered each of your comments, you may submit the form
  • e-mail Profile Authoring Group with general comments about the Profile/Protocol concept, structure, process, etc.

The QIBA Biomarker Committees consider all comments submitted, and where appropriate, post responses.

Public Comment Documents

see http://qibawiki.rsna.org/index.php/Profiles


Retrieved from "https://qibawiki.rsna.org/index.php?title=Work_Product_for_Review&oldid=19619"